Ionic Capital Management LLC cut its stake in Monsanto Company (NYSE:MON) by 93.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,601 shares of the basic materials company’s stock after selling 115,775 shares during the period. Ionic Capital Management LLC’s holdings in Monsanto were worth $974,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in MON. BlackRock Inc. increased its stake in shares of Monsanto by 2,390.1% in the first quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock valued at $2,965,029,000 after buying an additional 25,140,936 shares during the period. Flossbach Von Storch AG increased its stake in shares of Monsanto by 33.9% in the first quarter. Flossbach Von Storch AG now owns 4,089,400 shares of the basic materials company’s stock valued at $462,920,000 after buying an additional 1,034,400 shares during the period. UBS Asset Management Americas Inc. increased its stake in shares of Monsanto by 55.2% in the first quarter. UBS Asset Management Americas Inc. now owns 2,181,090 shares of the basic materials company’s stock valued at $246,899,000 after buying an additional 775,520 shares during the period. MARSHALL WACE ASIA Ltd acquired a new stake in shares of Monsanto during the first quarter valued at about $63,977,000. Finally, Massachusetts Financial Services Co. MA increased its position in Monsanto by 3.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 14,299,502 shares of the basic materials company’s stock worth $1,618,703,000 after buying an additional 499,639 shares during the last quarter. Institutional investors own 75.28% of the company’s stock.
Shares of Monsanto Company (NYSE MON) traded down 0.20% during midday trading on Friday, reaching $116.87. The company had a trading volume of 2,081,472 shares. Monsanto Company has a one year low of $97.35 and a one year high of $118.97. The company has a market capitalization of $51.34 billion, a PE ratio of 25.24 and a beta of 1.07. The company has a 50 day moving average of $117.38 and a 200 day moving average of $115.36.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion for the quarter, compared to analysts’ expectations of $4.18 billion. During the same period last year, the firm earned $2.17 earnings per share. The company’s revenue for the quarter was up 1.0% compared to the same quarter last year. Analysts predict that Monsanto Company will post $4.89 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be paid a dividend of $0.54 per share. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.85%. Monsanto’s dividend payout ratio (DPR) is currently 46.75%.
TRADEMARK VIOLATION NOTICE: “Monsanto Company (MON) Shares Sold by Ionic Capital Management LLC” was published by BNB Daily and is owned by of BNB Daily. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://www.baseball-news-blog.com/2017/08/19/ionic-capital-management-llc-cuts-position-in-monsanto-company-mon-updated-updated-updated.html.
A number of research analysts recently issued reports on the company. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. Barclays PLC increased their price objective on Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a report on Thursday, June 29th. Royal Bank Of Canada reissued a “sector perform” rating and set a $128.00 price target (up from $120.00) on shares of Monsanto in a research report on Thursday, June 29th. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a research report on Tuesday, July 4th. Finally, Citigroup Inc. reissued a “neutral” rating and set a $126.00 price target (up from $125.00) on shares of Monsanto in a research report on Monday, July 10th. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have issued a buy rating to the stock. Monsanto has a consensus rating of “Hold” and an average target price of $123.15.
In other news, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $117.95, for a total transaction of $6,181,759.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Steven Mizell sold 11,300 shares of the stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the sale, the executive vice president now owns 55,011 shares of the company’s stock, valued at $6,522,654.27. The disclosure for this sale can be found here. Insiders have sold 74,470 shares of company stock worth $8,791,281 over the last ninety days. Insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.